Guardant Health officer proposes $547K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardant Health, Inc. officer Terilyn J. Monroe reported a proposed sale of 3,842 common shares, with an aggregate market value of $547,149.00 and an approximate sale date of November 18, 2026. The notice names Charles Schwab & Co., Inc. as broker and lists 135,285,975 shares outstanding. The securities table lists 1,921 shares acquired through restricted stock lapse on each of July 1 and October 1, 2026. It gives August 19, 2026 as the plan adoption or instruction date under Rule 10b5-1.
Key Figures
Key Terms
Restricted Stock Lapse financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.